| Literature DB >> 369651 |
R J Walton, I T Sherif, G A Noy, K G Alberti.
Abstract
An alpha-glucosidehydrolase inhibitor (acarbose; BAY g 5421) taken with food was compared with dummy tablets in seven insulin-treated diabetic patients over eight-hour periods that included breakfast, lunch, and two snacks. Acarbose diminished the postprandial increases in blood glucose, lactate, and pyruvate concentrations and may therefore be of value in the management of insulin-dependent diabetes.Entities:
Mesh:
Substances:
Year: 1979 PMID: 369651 PMCID: PMC1597843 DOI: 10.1136/bmj.1.6158.220
Source DB: PubMed Journal: Br Med J ISSN: 0007-1447